Summary
In order to analyze the state of the natural resistance system of bladder cancer patients in vivo, we measured natural killer (NK) activity and NK cell subsets of peripheral blood lymphocytes (PBL) from 46 patients with bladder cancer and 25 age- and sex-matched healthy volunteers. The mean NK activity in patients with lowstage bladder cancer was similar to that in the controls, while NK activity in patients with high-stage bladder cancer was significantly depressed. The mean proportions of Leu7+ cells in patients with both low-stage and highstage bladder cancer were significantly higher than that in the controls. The mean proportion of Leu11a+ cells in patients with low-stage bladder cancer was similar to that in the controls, while in patients with high-stage bladder cancer it was significantly higher. This study demonstrates the abnormal immunological state of bladder cancer patients; namely, abnormalities exist not only in NK activity but also in the proportions of circulating NK cell subsets.
Similar content being viewed by others
References
Abo T, Miller CA, Gartland GL, Balch CM (1983) Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J Exp Med 157: 273
Balch CM, Tilden AB, Dougherty PA, Cloud GA, Abo T (1983) Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients. Ann Surg 198: 192
Britten V, Rees RC, Clegg A, Smith GT, Potter CW, Fox M, Williams JL (1982) Natural killer cell activity and response to phytohaemagglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder. Br J Urol 54: 261
Catalona WJ, Tarpley JL, Chretien PB, Castle JR (1974) Lymphocyte stimulation in urologic cancer patients. J Urol 112: 373
Herberman RB, Ortaldo JR (1981) Natural killer cells: Their role in defenses against disease. Science 214: 24
Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF (1983) Subpopulations of human natural killer cells defined by expression of the Leu7 (HNK-1) and Leu11 (NK-15) antigens. J Immunol 131: 1789
Lanier LL, Cwirla S, Federspiel N, Phillips JH (1986) Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor chain genes. J Exp Med 163: 209
Ma CP, Yu DS, Yeh MY, Chang SY, Han SH (1987) Natural killer cell activity in patients with urologic cancer. Eur Urol 13: 397
Marshall VF (1952) The relation to the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 68: 714
Minato N, Bloom BR, Jones C, Holland J, Reid LM (1979) Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med 149: 1117
Minato N, Reid L, Bloom BR (1981) On the heterogeneity of murine natural killer cells. J Exp Med 154: 750
Morales A, Ottenhof PC (1983) Clinical application of a whole blood assay for human natural killer (NK) cell activity. Cancer 52: 667
Morita T, Yonese Y, Minato N (1987) Evaluation of lymphocyte subpopulations in patients with bladder cancer: a study with monoclonal antibodies. Acta Urol Jpn 33: 838
Olsson CA, Rao CN, Menzoian JO, Byrd WE (1972) Immunologic unreactivity in bladder cancer patients. J Urol 107: 607
Polli N, Matutes E, Robinson D, Catovsky D (1987) Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold method. Clin Exp Immunol 68: 331
Saksela E, Tarkkanen J, Carpen O, Virtanen J (1982) Morphological and functional characteristics of human NK system. In: Serrou B, Rosenfeld C, Herberman RB (eds) Human cancer immunology: natural killer cells. Elsevier Biomedical Press, New York, pp 81–82
Schantz SP, Shillitoe EJ, Brown B, Campbell B (1986) Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst 77: 869
Steinhauer EH, Doyle AT, Reed J, Kadish AS (1982) Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. J Immunol 129: 2255
Takasugi M, Ramseyer A, Takasugi J (1977) Decline of natural non-selective cell mediated cytotoxicity in patients with tumor progression. Cancer Res 37: 413
UICC: Union Internationale Contre le Cancer (1978) TNM classification of malignant tumours. 3rd edn, International Union Against Cancer, Geneva
Zagury D, Morgan DA, Fouchard M, Bernard J, Feldman M, Herberman RB (1985) Heterogeneity of human natural killer cells. J Natl Cancer Inst 74: 553
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morita, T., Tokue, A. & Minato, N. Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer. Cancer Immunol Immunother 32, 191–194 (1990). https://doi.org/10.1007/BF01771456
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01771456